helping you live a happy, healthier life

Heart Health Menopause

When Your Lab Results Feel Like a Warning: What One Woman’s Story Teaches Us About Midlife, Hormones & Heart Health

“I thought I was doing everything right. Then I saw my labs. It felt like a warning bell.”

Meet Adrienne, a 52-year-old woman in the midst of perimenopause. She exercises regularly, eats well, doesn’t smoke, and has no major family history of heart disease. But a routine check-up revealed something that rattled her:

  • High cholesterol
  • High LDL
  • High ApoB
  • High HDL (yes, even the “good” cholesterol can be a red flag when out of balance) 3,4
  • Triglycerides normal

To make matters more confusing, her genetic report revealed a collection of variants linked to stress regulation, detoxification, cardiovascular risk, estrogen metabolism, and sleep disturbances.

Understandably, Adrienne was overwhelmed. What did all this mean? And what could she do about it — naturally and intelligently?

This is her story. And it might be yours, too.

🔬 Step 1: Interpreting the Numbers — What Adrienne’s Lab Results Reveal

Many women see a rise in cholesterol markers during the transition to menopause. But this isn’t about fat in food — it’s about fat metabolism under hormonal regulation. 1,2

Cholesterol: Slightly elevated overall – expected during estrogen decline. Cholesterol is a precursor to many hormones, so levels may rise as the body compensates.

LDL-C (“bad” cholesterol): High levels, especially when small and dense, can signal vascular inflammation. But we need context. 5

ApoB: A key marker of atherogenic risk. Each ApoB particle can carry cholesterol into artery walls. Higher levels = higher risk of plaque formation. 6

HDL-C (“good” cholesterol): Surprisingly high. While traditionally viewed as protective, excessively high HDL may reflect underlying inflammation or dysfunctional particle activity.

Triglycerides: Normal. A good sign, often connected to stable insulin and liver function.

This pattern — especially high ApoB and LDL-C with menopausal timing — tells us the system is shifting. The arteries are being challenged. But it doesn’t mean disease is inevitable.

🔮 Step 2: The Hormonal & Genetic Backdrop

Adrienne’s hormonal environment is changing dramatically:

  • Estradiol is dropping
  • Progesterone is fluctuating wildly
  • Cortisol is likely rising (exacerbated by chronic and hidden stress)

Her genetic testing revealed variants that provide insight into how her body might process this transition:

Stress & Mood Genes:

  • COMT, GAD1, DAT1, MAOA, FKBP5: These can impact how she metabolizes dopamine, adrenaline, and cortisol. Adrienne may experience heightened emotional reactivity, poor recovery from stress, and mood fluctuations [1,2].  7,11

Detoxification & Inflammation:

  • CYP1A2 (fast caffeine metabolizer), CYP3A4, GSTP1, SOD2: These influence how her liver clears hormones and environmental toxins. Adrienne may have greater oxidative stress burden, requiring stronger antioxidant support [3]. 13,14

Estrogen Metabolism:

  • CYP1A1, CYP1B1, CYP17A1: Influence estradiol conversion and breakdown. These can affect breast tissue sensitivity, cardiovascular function, and hormone therapy safety [4].

Cardiovascular Risk Genes:

  • APOE, MMP3, IL6, ACE: Modulate lipid metabolism, vascular repair, and inflammatory response. When combined with lifestyle stressors, they can increase atherosclerosis risk [5]. 8

Sleep & Recovery Genes:

  • CLOCK, CRY1: Can disrupt circadian rhythm, melatonin output, and metabolic repair [6]. 9,10

Cholesterol Handling:

  • LDLR (low-density lipoprotein receptor gene): Key for clearing cholesterol from the bloodstream. If variants impair function, LDL and ApoB can rise [7].

In short, Adrienne isn’t broken. Her body is uniquely wired. Her lab results are not a condemnation — they’re a personalized map.

🏡 Step 3: The Life Context — What Has She Carried Until Now?

Adrienne is not just her biochemistry. She’s a woman who has raised a family, worked through career changes, coped with aging parents, and always tried to “be healthy.”

But the reality is:

  • Chronic low-grade stress was always simmering beneath the surface.
  • She rarely prioritized recovery or deep rest.
  • Her workouts were intense, but her nervous system was never regulated.
  • She ate well, but not with her genes and hormones in mind.
  • Her social support was limited, and her emotional bandwidth stretched thin.

Unresolved emotional stress, overexercising, and overreliance on willpower can accumulate and tip the scale. For Adrienne, perimenopause became the tipping point.

🧬 Step 4: What We Did — Personalized, Layered Interventions

Rather than reach for a statin or an antidepressant, Adrienne chose a more functional, root-cause path.

1. Nervous System & Stress Reset

  • Neuro Emotional Technique (NET) to address unconscious stress imprints
  • Vagal nerve toning: breathwork, cold exposure, gentle movement
  • Establishing consistent sleep-wake cycles and reducing blue light exposure
  • Adaptogenic herbs (ashwagandha, rhodiola) for cortisol modulation

2. Nutrition for Her Genes & Heart

  • Increased soluble fiber (chia, lentils, oats) to bind excess cholesterol
  • Added plant sterols and cruciferous vegetables for estrogen detox support
  • Phytonutrients (e.g., pomegranate, cocoa, berries) to boost antioxidant protection
  • Reduced alcohol and caffeine (based on CYP1A2 + sleep gene variants)

3. Gentle Hormonal Support

  • Flax and red clover (phytoestrogens) to modulate estrogen receptors
  • Bioidentical progesterone to support sleep and calm the nervous system
  • With guidance, exploring transdermal estradiol after evaluating estrogen metabolism genes 12

4. Anti-inflammatory Lifestyle Upgrades

  • Swapped high-intensity workouts for gene-informed interval training
  • Daily walks in nature, grounding exercises, barefoot outdoor time
  • Added curcumin, omega-3s, magnesium, and CoQ10
  • Scheduled relaxation and joyful activity, not just “to-do lists”
  • Probiotics to enhance estrogen clearance (estrobolome health)
  • Liver support: glutathione, NAC, milk thistle, dandelion, and B vitamins
  • Filtered water, cleaner household products, and toxin reduction at home
  • Elimination of endocrine-disrupting chemicals from skincare and cookware

📊 Step 5: The Outcome — Confidence & Calm

Within 3 months:

  • Adrienne’s LDL dropped by 15%, and her ApoB improved
  • She reported better sleep, more energy, fewer hot flashes
  • Anxiety was lower, her digestion improved, and her outlook changed
  • Her inflammatory markers also began to decline (hs-CRP, homocysteine)

But more importantly:

  • She understood her body and stopped fearing it
  • She saw her genes as guidance, not destiny
  • She began living with clarity, instead of panic
  • She felt empowered to take charge of her next chapter
🔍 Sidebar Feature: What Do These Markers Really Mean?
MarkerWhat it Tells Us
LDL-CPrimary cholesterol carrier linked to plaque
ApoBNumber of particles delivering cholesterol
HDL-CCholesterol retrieval; high isn’t always protective
TriglyceridesBlood fats; high = metabolic dysfunction
hs-CRPSystemic inflammation marker
HomocysteineMethylation and heart risk marker
🌿 The Takeaway

Midlife lab results don’t have to be a threat. They can be an invitation.

Adrienne’s story shows us that when we:

  • Investigate instead of fear
  • Personalize instead of standardize
  • Support instead of suppress

…we can heal forward, not just backwards.

There is so much you can do when your body is seen, heard, and supported.

🔬 Scientific References

1. Derby CA, Crawford SL, Pasternak RC, et al. Lipid Changes During the Menopause Transition in Relation to Age and Weight: The SWAN Study. Am J Epidemiol. 2009;169(11):1352-1361. doi:10.1093/aje/kwp043 https://doi.org/10.1093/aje/kwp043

2. El Khoudary SR, Chen X, Nasr A, et al. HDL Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study. Arterioscler Thromb Vasc Biol. 2021;41(9):2545-2554. doi:10.1161/ATVBAHA.120.315355 https://doi.org/10.1161/ATVBAHA.120.315355

3. Madsen CM, Varbo A, Nordestgaard BG. Extreme high HDL cholesterol is paradoxically associated with high mortality in men and women. Eur Heart J. 2017;38(32):2478-2486. doi:10.1093/eurheartj/ehx163 https://doi.org/10.1093/eurheartj/ehx163

4. El Khoudary SR, Aggarwal B, Beckie TM, et al. HDL and the menopause. Curr Opin Lipidol. 2017;28(4):322-329. doi:10.1097/MOL.0000000000000432 https://doi.org/10.1097/MOL.0000000000000432

5. Arterioscler Thromb Vasc Biol. 2014;34(5):? Small Dense LDL-C and CHD risk. doi:10.1161/ATVBAHA.114.303284 https://doi.org/10.1161/ATVBAHA.114.303284

6. Ference BA, Kastelein JJP, Ray KK, et al. Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease per unit change in ApoB. JAMA. 2019;321(4):364-373. doi:10.1001/jama.2018.20045 https://doi.org/10.1001/jama.2018.20045

7. Buchanan TW, et al. The role of genetics in stress effects on health and addiction. Psychoneuroendocrinology. 2018;? doi:10.1016/j.psyneuen.2018.02.021 https://doi.org/10.1016/j.psyneuen.2018.02.021

8. Poredoš P, Jezovnik MK. Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms and Peripheral Arterial Disease. Int J Mol Sci. 2022;23(19):12054. doi:10.3390/ijms231912054 https://doi.org/10.3390/ijms231912054

9. Semenova NV, Knyazev RA, Mitrofanova LB, et al. 3111T/C Clock Gene Polymorphism in Women with Insomnia. Bull Exp Biol Med. 2017;163(4):461-464. doi:10.1007/s10517-017-3828-5 https://doi.org/10.1007/s10517-017-3828-5

10. Patke A, Murphy PJ, Onat OE, et al. Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder. Cell. 2017;169(2):203-215.e13. doi:10.1016/j.cell.2017.03.027 https://doi.org/10.1016/j.cell.2017.03.027

11. Zannas AS, Arloth J, Carrillo-Roa T, et al. Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB–driven inflammation and cardiovascular risk. Proc Natl Acad Sci U S A. 2019;116(23):11370-11379. doi:10.1073/pnas.1816847116 https://doi.org/10.1073/pnas.1816847116

12. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354(3):270-282. doi:10.1056/NEJMra050776 https://doi.org/10.1056/NEJMra050776

13. Strehlow K, Rotter S, Wassmann S, et al. Modulation of Antioxidant Enzyme Expression and Function by Estrogen. Circ Res. 2003;93:170–177. doi:10.1161/01.RES.0000082334.17947.11 https://doi.org/10.1161/01.RES.0000082334.17947.11

14. Doshi SB, Agarwal A. The role of oxidative stress in menopause. J Midlife Health. 2013;4(3):140–146. doi:10.4103/0976-7800.118990 https://doi.org/10.4103/0976-7800.118990

Recommended Articles